Panic Disorder
📧 Sign up to get email alerts when something new happens for Panic Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Metacognitive Therapy vs Unified Protocol for Patients With Comorbid Anxiety Disorders [NA]
This clinical trial from Karolinska Institutet compares metacognitive therapy to a unified protocol for patients with comorbid anxiety disor…
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Psychoeducation Based on Acceptance and Commitment Therapy [NA]
A clinical trial update from Muğla Sıtkı Koçman University evaluating psychoeducation based on Acceptance and Commitment Therapy for panic d…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Investigations of Factors Associated With Treatment Response and Prognosis in Anxiety Disorders
This clinical trial update describes investigations into factors associated with treatment response and prognosis in Panic Disorder, a form …
-
FDA approval · 2025-04-23FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for venlafaxine hydrochloride submitted by Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2025-04-13Clinical Trial Update: The Relationship Between Panic Attack Symptoms and Atrial Fibrillation Episodes.
The document reports that a clinical trial studying the relationship between panic attack symptoms and paroxysmal atrial fibrillation has be…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Evaluation of Primary Care Behavioral Health (PCBH) With the Addition of Self-help CBT - A Randomized Multicenter Trial [NA]
A multicenter randomized trial evaluating primary care behavioral health with added self-help CBT is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD) [Phase 4]
Phase 4 clinical trial evaluating ziprasidone for bipolar disorder with comorbid lifetime panic disorder or generalized anxiety disorder; re…
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Treatment of Anxiety Disorders With Trigeminal Nerve Stimulation [NA]
A clinical trial evaluating trigeminal nerve stimulation for anxiety disorders is currently active but not recruiting. The conditions includ…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Optimizing Exposure Therapy for Anxiety Disorders [NA]
A UCLA-sponsored clinical trial evaluating exposure therapy optimization for social anxiety disorder and panic disorder has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: A Study to Evaluate Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder [Phase 2]
AbbVie completed a Phase 2 study evaluating the efficacy, safety, and tolerability of darigabat in participants with panic disorder.
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Safety and Efficacy of HB-1 for Panic Disorder [Phase 2]
Phase 2 trial of HB-1 for panic disorder completed and results posted, detailing safety and efficacy outcomes.
-
FDA approval · 2025-03-13FDA Approved: PAROXETINE — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for paroxetine hydrochloride (paroxetine) as a generic product under NorthStar Rx LLC's ANDA.
-
FDA approval · 2025-02-28FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for paroxetine hydrochloride from Zydus Lifesciences Limited, adding regulatory approval for this ge…
-
FDA approval · 2025-02-15FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (XLCare Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Sertraline Hydrochloride from XLCare Pharmaceuticals, Inc., authorizing the generic product.
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Investigating the Impacts of Early Life Experience on the Brain & Behaviour
The University of Manchester reports an ongoing recruiting study investigating how early life experiences influence brain and behavior relat…
-
FDA approval · 2025-02-11FDA Approved: PAROXETINE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for paroxetine (Padagis US LLC), updating the labeling to reflect expanded indications for the antid…
-
FDA approval · 2025-01-29FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for sertraline hydrochloride (generic sertraline), authorizing the generic prod…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Evaluating Clinical Routines for ICBT [NA]
Update on a clinical trial evaluating internet-delivered cognitive behavioral therapy (ICBT) for depression, panic disorder, and social anxi…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Parent-based Treatment for Youth With Anxiety and Obsessive-compulsive Disorder [NA]
This clinical trial update reports results for a parent-based treatment approach for youth with obsessive-compulsive disorder and other anxi…
-
FDA approval · 2024-11-07FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for Accord Healthcare's sertraline hydrochloride, a generic version of sertraline, maintaining the u…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Anxiety is One of the Most Frequent Disorders During the Perinatal Stage Which is Associated with Adverse Health Effects for Women and Their Babies. This Study Will Be to Evaluate the Effectiveness of a Telematic Cognitive-behavioral Preventive Intervention to Manage Anxiety During Pregnancy. [NA]
A clinical trial is evaluating the effectiveness of a telematic cognitive-behavioral preventive intervention to manage anxiety during pregna…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: The Effectiveness of Transdiagnostic CBT Protocol on Anxiety Disorders [NA]
Clinical trial from Ibn Haldun University evaluating a transdiagnostic CBT protocol for anxiety disorders, including social anxiety disorder…
-
FDA approval · 2024-09-13FDA Approved: FLUOXETINE HCL — Original Application (Strides Pharma Science Limited)
FDA approved a generic fluoxetine hydrochloride product from Strides Pharma Science Limited via an original ANDA. The approval confirms the …
-
FDA approval · 2024-08-29FDA Approved: PAROXETINE — Supplemental Application (Modavar Pharmaceuticals LLC)
The FDA approved a supplemental application for paroxetine from Modavar Pharmaceuticals LLC.
-
FDA approval · 2024-08-29FDA Approved: FLUOXETINE HYDROCHLORIDE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA approved the supplemental application for Fluoxetine Hydrochloride from Taro Pharmaceuticals U.S.A., Inc. (ANDA211477), enabling the mar…